Standard BioTools (LAB) vs Pacific Biosciences of California (PACB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Pacific Biosciences of California (PACB) has outperformed Standard BioTools (LAB) over the past year, gaining 94.3% versus a loss of 47.8%. Over five years, LAB leads with a -87.3% price change compared with -88.8% for PACB. Pacific Biosciences of California is the larger company by market cap ($845.5 million vs $266.4 million), about 3.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LAB | PACB |
|---|---|---|
| Share price | $0.6787 | $2.72 |
| Market cap | $266.44M | $845.46M |
| 1-day change | -6.00% | +0.74% |
| YTD return | -46.98% | +45.45% |
| 1-year return | -47.79% | +94.29% |
| 5-year return | -87.29% | -88.85% |
| EPS (TTM) | $-0.13 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.72 | $3.44 |
| 52-week low | $0.63 | $1.07 |
| Distance from 52-week high | -60.54% | -20.93% |
| Average volume | 1.57M | 9.85M |
| Shares outstanding | 392.58M | 310.83M |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Pacific Biosciences of California is about 3.2 times larger than Standard BioTools by market value ($845.46M vs $266.44M).
- PACB has outperformed LAB by 142.1 percentage points over the past year.
LAB vs PACB FAQ
Which is bigger, Standard BioTools or Pacific Biosciences of California?
Pacific Biosciences of California (PACB) is larger, with a market capitalization of $845.46M compared with $266.44M for Standard BioTools (LAB).
Which stock has performed better over the past year, LAB or PACB?
PACB returned +94.29% over the past 12 months, compared with -47.79% for LAB (price return, excluding dividends). Past performance does not predict future results.
Are Standard BioTools and Pacific Biosciences of California in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.